Cantor Fitzgerald upgraded shares of Quantinuum (NASDAQ:QNT – Free Report) to a strong-buy rating in a research report report published on Monday,Zacks.com reports.
Several other brokerages have also commented on QNT. UBS Group assumed coverage on shares of Quantinuum in a research report on Monday. They issued a “buy” rating and a $93.00 price objective for the company. Morgan Stanley began coverage on shares of Quantinuum in a research note on Monday. They set an “equal weight” rating and a $78.00 price target on the stock. Bank of America initiated coverage on shares of Quantinuum in a research note on Monday. They set a “buy” rating and a $100.00 price objective for the company. Craig Hallum initiated coverage on shares of Quantinuum in a report on Monday. They set a “buy” rating and a $100.00 price objective on the stock. Finally, Evercore began coverage on Quantinuum in a research report on Monday. They issued an “outperform” rating and a $98.00 target price on the stock. Three equities research analysts have rated the stock with a Strong Buy rating, nine have given a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus price target of $98.75.
Get Our Latest Stock Report on QNT
Quantinuum Stock Performance
Insider Transactions at Quantinuum
In other Quantinuum news, Director Paul R. Daugherty purchased 4,000 shares of Quantinuum stock in a transaction on Friday, June 5th. The stock was bought at an average cost of $60.00 per share, with a total value of $240,000.00. Following the transaction, the director owned 9,833 shares of the company’s stock, valued at $589,980. This represents a 68.58% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Michal Stepniak acquired 13,333 shares of the firm’s stock in a transaction on Friday, June 5th. The shares were acquired at an average price of $60.00 per share, with a total value of $799,980.00. Following the completion of the purchase, the director owned 13,333 shares in the company, valued at approximately $799,980. This trade represents a ? increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have bought 411,032 shares of company stock valued at $24,661,920 over the last quarter.
Quantinuum News Roundup
Here are the key news stories impacting Quantinuum this week:
- Positive Sentiment: Multiple firms initiated coverage on Quantinuum with bullish calls, including JPMorgan, Rosenblatt, Craig Hallum, Bank of America, Needham, Mizuho, and Sanford C. Bernstein, with several price targets implying meaningful upside. Analyst coverage and price targets
- Positive Sentiment: Rosenblatt was the most bullish, assigning a buy rating and a $155 target, signaling strong confidence in Quantinuum’s long-term growth potential. Rosenblatt coverage
- Positive Sentiment: Congressional trading activity also drew attention after Rep. Cleo Fields reportedly made a new quantum-related bet, adding to investor interest in the sector. Congressman Who Buys Magnificent Seven Stocks With Size Made New Quantum Bet
- Neutral Sentiment: Morgan Stanley initiated coverage with an equal weight rating and a $78 target, which is more cautious than peers but still above the recent trading level. Morgan Stanley coverage
- Negative Sentiment: Despite the bullish analyst wave, the stock has been falling, suggesting investors may be taking profits or reacting to valuation concerns after the sharp run-up in interest around quantum computing. Quantinuum stock falls: why is Wall Street bullish on the stock?
Quantinuum Company Profile
Quantinuum is a quantum computing company focused on developing hardware and software for commercial and scientific applications. The company provides access to its quantum systems, along with software tools and services designed to help customers explore use cases in areas such as optimization, materials science, chemistry, cybersecurity, and machine learning.
The company was formed through the combination of Honeywell Quantum Solutions and Cambridge Quantum in 2021. Quantinuum operates internationally and serves a range of customers across enterprise, government, and research markets.
See Also
- Five stocks we like better than Quantinuum
- The AI Boom Has a Second Act—And It’s Playing Out in Optics
- Gold’s 2026 Rally Has Cracked—Is It Time to Buy the Pullback?
- 5 Tech Stocks to Buy on the July Pullback
- Is OpenAI’s IPO Delay a Warning for AI Investors?
Receive News & Ratings for Quantinuum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantinuum and related companies with MarketBeat.com's FREE daily email newsletter.
